Inventor · disambiguated record
Markus Dahlgren
Also filed as: DAHLGREN MARKUS · DAHLGREN MARKUS K · DAHLGREN MARKUS KRISTOFER
16 granted patents·7 pending applications·70 citations·filing 2015–2023
91Inventor score
Files withNIMBUS LAKSHMI INC12HIBERCELL INC4RELAY THERAPEUTICS INC4PETRA PHARMA CORP2MERCK SHARP & DOHME1
Top patents by PatentIndex Score
23 records- 0198US10253046B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Apr 9, 2019·14 cites·12 claims
- 0297US10023571B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2016·Granted Jul 17, 2018·15 cites·17 claims
- 0392US10968236B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Apr 6, 2021·3 cites·14 claims
- 0492US10196390B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Feb 5, 2019·10 cites·14 claims
- 0589US9630970B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2016·Granted Apr 25, 2017·7 cites·7 claims
- 0689US9340540B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2015·Granted May 17, 2016·7 cites·20 claims
- 0786US11701354B2Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Jul 18, 2023·3 cites·40 claims
- 0885US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 0984US10781204B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Sep 22, 2020·3 cites·8 claims
- 1081US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 1181US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 1281US2023391797A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2022·Application pending·0 cites
- 1378US11667651B2Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Jun 6, 2023·1 cites·11 claims
- 1478US2023074228A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2022·Application pending·0 cites
- 1573US2021238198A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 1670US2024158415A1Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 1768US11434240B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Sep 6, 2022·0 cites·17 claims
- 1866US2023286960A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1964US2016251376A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2016·Application pending·0 cites
- 2049US2020392161A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2143US11584763B2Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Feb 21, 2023·0 cites·16 claims
- 2240US11919902B2Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Mar 5, 2024·0 cites·13 claims
- 2340US10875851B2Factor XIIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 29, 2020·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →